Showing results (481-490 of 2,440) with videos related to
Sort By:
Pageof 244
Clinical and Translational Science|August 22, 2024
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participantsAnees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, et al.Clinical and Translational Science|December 2, 2024
Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitorsJun Okui, Takashi Waki, Kazuhiro Kajiyama, et al.Clinical and Translational Science|October 28, 2024
Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug developmentAna Victoria Ponce-Bobadilla, Vanessa Schmitt, Corinna S Maier, et al.Clinical and Translational Science|November 15, 2024
Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditisShigeru Toyoda, Masashi Sakuma, Kazuyuki Ishida, et al.Clinical and Translational Science|November 4, 2024
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adultsRupert Davies, Stanford L Peng, Jason Lickliter, et al.Clinical and Translational Science|August 9, 2024
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimodQiudi Jiang, Yuchen Zhang, Dan Duan, et al.Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.Clinical and Translational Science|July 17, 2024
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairmentRajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, et al.Clinical and Translational Science|July 9, 2024
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexantIngrid Koopmans, Daphne Geerse, Lara de Ridder, et al.Clinical and Translational Science|August 2, 2024
A case study of inclusion of rural populations in research: Implications for science and health equityDevon Noonan, Wendy K K Lam, James Goodrich, et al.Pageof 244